Wound Biofilm Therapeutics Market size is valued at USD 1.73 billion in 2021 and is expected to reach USD 2.78 billion by 2028, at a CAGR of 8.2% during the forecast period 2022-2028. Wound biofilm therapeutics are used to combat the wound biofilms that are a type of infection made up of living microorganisms by forming colonies. These are caused by various species such as fungi, bacteria, yeast, algae, and other microorganisms. Biofilm is formed when microbes attached themselves to surface of wounds by secreting gummy substance. Formation of biofilms leads to chronic infection and non-healing wounds. Wound biofilms occurs on the chronic wounds such as diabetic foot ulcers, venous leg ulcers, pressure or decubitus ulcers, and surgical site infections. Most of the Wound Biofilm Therapeutics Market players are focused on the R&D activities for the innovation of newer platforms to cure the wound biofilms. For instance, this report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, The global Wound Biofilm Therapeutics Market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global Market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities).